Darl D. Flake

Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study

Jack Cuzick, Gregory P. Swanson, Gabrielle Fisher et al. · The Lancet Oncology · 2011 · 800 citations · Full text

Somatic Mutations in <i>BRCA1</i> and <i>BRCA2</i> Could Expand the Number of Patients That Benefit From Poly (ADP Ribose) Polymerase Inhibitors in Ovarian Cancer

Bryan T. Hennessy, Kirsten M. Timms, Mark Carey et al. · Journal of Clinical Oncology · 2010 · 368 citations · Full text

Clinical validation of a gene expression signature that differentiates benign nevi from malignant melanoma

Loren E. Clarke, M. Bryan Warf, Darl D. Flake et al. · Journal of Cutaneous Pathology · 2015 · 153 citations · Full text

BRCA1/2 mutations and expression: Response to platinum chemotherapy in patients with advanced stage epithelial ovarian cancer

Rebecca Dann, Julie A. DeLoia, Kirsten M. Timms et al. · Gynecologic Oncology · 2012 · 129 citations

Medicine, Brca1/2 Mutations, Pathology +8

An independent validation of a gene expression signature to differentiate malignant melanoma from benign melanocytic nevi

Loren E. Clarke, Darl D. Flake, Klaus J. Busam et al. · Cancer · 2016 · 110 citations · Full text